Sinonasal NUT carcinoma: clinicopathological and cytogenetic analysis with autopsy findings
H Minato, E Kobayashi, S Nakada, N Kurose… - Human pathology, 2018 - Elsevier
Nuclear protein in testis (NUT) carcinoma is a rare malignant neoplasm with an
undifferentiated morphology. Its diagnosis is often difficult, especially as the sinonasal tract …
undifferentiated morphology. Its diagnosis is often difficult, especially as the sinonasal tract …
[HTML][HTML] NUT midline carcinoma: an aggressive intrathoracic neoplasm
SA Parikh, CA French, BA Costello, RS Marks… - Journal of Thoracic …, 2013 - Elsevier
Nuclear protein in testis (NUT) midline carcinoma (NMC) is a poorly differentiated squamous
cell carcinoma that is characterized by a balanced translocation between chromosomes 15 …
cell carcinoma that is characterized by a balanced translocation between chromosomes 15 …
[引用][C] NUT Midline Carcinoma in a Young Woman
Discussion NUT carcinoma is an aggressive and invariably fatal carcinoma that generally
affects young adults. 1 As a clinicopathologic entity, it has, to our knowledge, only been …
affects young adults. 1 As a clinicopathologic entity, it has, to our knowledge, only been …
Phase 1 study of molibresib (GSK525762), a bromodomain and extra-terminal domain protein inhibitor, in NUT carcinoma and other solid tumors
SA Piha-Paul, CL Hann, CA French… - JNCI Cancer …, 2020 - academic.oup.com
Background Bromodomain and extra-terminal domain proteins are promising epigenetic
anticancer drug targets. This first-in-human study evaluated the safety, recommended phase …
anticancer drug targets. This first-in-human study evaluated the safety, recommended phase …
Therapeutic impact of BET inhibitor BI 894999 treatment: Backtranslation from the clinic
U Tontsch-Grunt, PE Traexler, A Baum, H Musa… - British Journal of …, 2022 - nature.com
Background BET inhibitors have been tested in several clinical trials where, despite
encouraging preclinical results, substantial clinical benefit in monotherapy remains limited …
encouraging preclinical results, substantial clinical benefit in monotherapy remains limited …
NUT midline carcinoma of the sublingual gland: clinical presentation and review
NB Seim, RHW Philips, L Schoenfield… - Head and neck …, 2017 - Springer
NUT midline carcinoma (NMC) is a rare and aggressive disease encountered in the midline
of the head and neck or mediastinum. Due to its sparse incidence and subtle pathologic …
of the head and neck or mediastinum. Due to its sparse incidence and subtle pathologic …
BET proteins as targets for anticancer treatment
A Stathis, F Bertoni - Cancer discovery, 2018 - AACR
Bromodomain and extraterminal domain (BET) proteins are epigenetic readers that regulate
gene expression and are involved in cancer pathogenesis. Over the last years, several BET …
gene expression and are involved in cancer pathogenesis. Over the last years, several BET …
Demystifying NUT midline carcinoma: radiologic and pathologic correlations of an aggressive malignancy
RJ Bair, JF Chick, NR Chauhan… - American Journal of …, 2014 - Am Roentgen Ray Soc
OBJECTIVE. NUT midline carcinoma is a rare poorly differentiated aggressive subtype of
squamous cell carcinoma. To date, fewer than 100 total cases have been reported …
squamous cell carcinoma. To date, fewer than 100 total cases have been reported …
Supercharging BRD4 with NUT in carcinoma
KP Eagen, CA French - Oncogene, 2021 - nature.com
NUT carcinoma (NC) is an extremely aggressive squamous cancer with no effective therapy.
NC is driven, most commonly, by the BRD4-NUT fusion oncoprotein. BRD4-NUT combines …
NC is driven, most commonly, by the BRD4-NUT fusion oncoprotein. BRD4-NUT combines …
NUT midline carcinoma: report of 2 cases suggestive of pulmonary origin
M Tanaka, K Kato, K Gomi, M Yoshida… - The American journal …, 2012 - journals.lww.com
In this study, we report 2 pediatric cases of nuclear protein of the testis (NUT) midline
carcinoma (NMC) suggestive of pulmonary origin: case 1 was a 14-year-old Japanese boy …
carcinoma (NMC) suggestive of pulmonary origin: case 1 was a 14-year-old Japanese boy …